Document is current
Any future updates will be listed below
-
Authors
Antza, Christina https://orcid.org/0000-0001-5164-7435
Rizos, Christos V.
Kotsis, Vasileios
Liamis, George
Skoumas, Ioannis
Rallidis, Loukianos
Garoufi, Anastasia
Sfikas, George
Kolovou, Genovefa
Penopoulos, Athanasios
Skalidis, Emmanouil
Stamatelopoulos, Kimon
Doumas, Michalis https://orcid.org/0000-0002-7269-8044
Lambadiari, Vaia
Anagnostis, Panagiotis
Mavrokefalou, Evgenia https://orcid.org/0009-0003-0692-5477
Boufidou, Amalia
Giannakopoulou, Vasiliki
Anastasiou, Georgia
Petkou, Ermioni
Vlachopoulos, Charalambos https://orcid.org/0000-0002-9904-3558
Dima, Ioanna https://orcid.org/0000-0002-4380-4493
Fakas, Georgios https://orcid.org/0009-0002-6178-4868
Papathanasiou, Konstantinos A. https://orcid.org/0000-0003-0123-2615
Attilakos, Achilleas https://orcid.org/0000-0002-8032-9994
Koumaras, Charalambos
Kolovou, Vana
Agapakis, Dimitrios
Zacharis, Evangelos
Moustou, Chrysoula
Katsiki, Niki https://orcid.org/0000-0003-0894-2644
Kountouri, Aikaterini
Mpellou, Eleni
Prodromiadou, Elisavet
Liberopoulos, Evangelos
- License Information
-
More Information
Article History
Received: 4 March 2025
Revised: 7 July 2025
Accepted: 15 July 2025
First Online: 21 July 2025
Competing interests
: CA, CVR, GL, AG, GS, PA, VK, GA, EP, ID, FG, KAP, AA, VK, CK, DA, CB, EM, AP have nothing to declare. IS has given talks, received honoraria, and participated in clinical trials sponsored by MSD, AMGEN, SANOFI. LR has received research grants and honoraria from Amgen, Sanofi-Aventis, Viatris, Novartis, Vianex and Servier. GK has given talks, attended conferences and participated in trials sponsored by Amgen, Angelini, MSD, Lilly, Vianex and Sanofi and has also accepted travel support to conferences from Amgen, Sanofi and MSD. ES has participated in educational and advisory activities sponsored by AstraZeneca, Medtronic, MSD, Sanofi and Servier. VK has given talks and attended conferences sponsored by AstraZeneca, MSD, Sanofi-Aventis, and Vianex. MD has given lectures for and participated in trials sponsored by Novo-Nordisc, Astra-Zeneca, Novartis, Eli-Lilly, Menarini, WinMedica, Innovis, Boehringer, Elpen, Viatris KS has received honoraria from Amgen. VL has given lectures, attended conferences and participated in trials sponsored by Novo Nordisk, Sanofi-Aventis, Novartis, AstraZeneca, Boehringer-Ingelheim, MSD, GSK, Vianex, Elli Lilly, ELPEN, Mylan and Aegereon. AB has received honoraria from Vianex, Amarin and Sanofi. EL has participated in educational, research and advisory activities sponsored by AstraZeneca, MSD, Lilly, Bayer, Amgen, Sanofi, Boehringer-Ingelheim, Novartis, Novo Nordisk, Valeant and Servier. EZ has received honoraria for lectures from Amgen. Sanofi, MSD, and Astra Zeneca. CV has received research grants and fees for scientific activities from Amgen, AstraZeneca, Boehringer-Ingelheim, ELPEN, Mylan, Novartis, Sanofi, MSD, and Vianex. HM participated in educational, research and consulting activities supported by healthcare companies, including Amgen, AstraZeneca, Boehringer Ingelheim, Elpen, Novartis, Sanofi, Vianex, Ultragenyx, Winmedica. ENL has participated in educational, research and advisory activities sponsored by AstraZeneca, MSD, Lilly, Bayer, Amgen, Sanofi, Boehringer Ingelheim, Novartis, Novo Nordisk, Valeant and Servier.
: The study protocol was approved by all institutions’ scientific and ethics committees and the Hellenic Data Protection Authority. All methods were performed in accordance with the relevant guidelines and regulations. Written informed consent was obtained from all participants prior to inclusion in the registry.
